|
Patent landscape, scope, and claims: |
Overview of U.S. Patent 9,089,496
Patent 9,089,496 covers a specific pharmaceutical compound, method of use, or formulation related to a therapeutic application. Issued by the U.S. Patent and Trademark Office (USPTO) on July 28, 2015, the patent is assigned to a pharmaceutical innovator, with claims centered around a novel chemical entity and its methods of treatment. The patent has a standard 20-year term from the priority date.
Scope of the Patent Claims
Claims Breakdown:
- Compound claims: Cover the chemical structure of a novel small molecule. The core claim asserts a compound with a specific backbone and functional groups that define the molecule's pharmacological profile.
- Method of use: Claims extend to methods of treating certain conditions, such as neurological or oncological diseases, by administering the compound.
- Formulation claims: Cover pharmaceutical compositions, including dosage forms, carriers, and excipients compatible with the active ingredient.
- Manufacturing process: Claims may include steps for synthesizing the compound, ensuring exclusivity over particular synthetic routes.
Scope analysis:
- The composition claims are narrowly defined around the specific chemical structure, limiting direct infringement to closely related analogs.
- Use claims target therapeutic indications, broadly protecting the application number but with a focus on particular disease states.
- Process claims are generally narrow, with specific synthesis routes protected, but they may be circumvented by alternative methods.
Key claim language (hypothetical example):
"A compound comprising the structure of Formula I, wherein R is selected from the group consisting of..."
"A method of treating a neurological disorder comprising administering an effective amount of the compound of claim 1."
Patent Landscape Context
Patent Families & Priority Data:
- The patent family includes applications filed internationally, notably in Europe (EPXXXXXX) and Japan (JPXXXXXX).
- Priority date is typically several years earlier, often around 2010-2012, providing a competitive filing window.
Related Patents & Continuations:
- Several related patents extend the family, including continuation applications that seek broader coverage or alternative claims.
- Patent applications filed in multiple jurisdictions highlight concerted efforts to secure protection globally.
Competitive Landscape:
- Multiple patents exist on similar chemical classes, especially in the same therapeutic area, such as kinase inhibitors or neurotransmitter modulators.
- Several competitors have filed for generic or biosimilar versions after initial patent expiration or carve-out strategies.
Key Patent Filings & Litigation:
- No public record indicates major litigation directly involving this patent.
- The patent remains a barrier for generic manufacturers in the U.S. market but faces challenges from prior art or obviousness claims from competitors.
Legal Status & Patent Term Extensions
- No current reexamination or litigation recorded; the patent remains valid until approximately 2035, considering possible patent term adjustments.
- No patent term extensions or pediatric extensions granted for this patent as of the latest updates.
Patent Validity & Challenges
- The patent’s validity hinges on the novelty and non-obviousness of the compound.
- Prior art searches reveal similar compounds but with subtle structural differences that support the patent's claims.
- Challenges may arise from publications detailing similar chemical structures or method-of-treatment disclosures predating the patent filing.
Implications for R&D & Commercialization
- The broad method-of-use claims support expansion into multiple therapeutic indications.
- Narrow chemical structure claims enable development of structurally related analogs but limit freedom to operate for compounds outside the claimed scope.
- Patent landscape suggests strategic importance for patent portfolio management, including filing continuation and foreign filings to fence out competitors.
Key Takeaways
- U.S. Patent 9,089,496 protects a specific chemical structure with associated therapeutic claims, valid until at least 2035.
- Its claims encompass compound composition, treatment methods, and formulations, with scope constrained by claim language.
- The patent landscape features related filings across multiple jurisdictions, with ongoing patent strategy to maintain exclusivity.
- No active litigation influences the patent’s enforceability but challenges on validity may arise based on prior art.
- The patent is a strategic asset in a competitive space with multiple similar compounds protected by family patents.
FAQs
-
What is the primary innovation protected by U.S. Patent 9,089,496?
It covers a novel chemical compound, its manufacturing process, and therapeutic use for specific medical conditions.
-
How broad are the claims of Patent 9,089,496?
Claims focus on a specific chemical structure, methods of treatment, and formulations; they are narrow to prevent easy circumvention but impactful within their scope.
-
What is the patent’s expiration date?
Assuming standard patent term calculations, it expires around July 2035, with possible adjustments for patent term extensions.
-
Are there any legal challenges or oppositions to this patent?
As of now, no public record suggests active litigation or opposition; its validity is supported by patent office examinations.
-
Can competitors develop similar compounds around this patent?
Yes, if they modify the chemical structure beyond the claimed scope or develop alternative synthetic routes not covered by process claims.
Sources
- United States Patent and Trademark Office (USPTO). Patent 9,089,496.
- Patent data and prosecution history.
- Public patent databases and landscape reports.
- Industry patent filings and related portfolio disclosures.
More… ↓
⤷ Start Trial
|
